Download Life Members - AAISCR.....

Life Members
Life Members & Contact
Bharat B. AGGARWAL, Ph.D. (U.C., Berkeley)
UT M. D. Anderson Cancer Center
Houston, TX
[email protected]
Research Interest &
Hobbies
Inflammation and
cancer, cytokines, NFkβ
Dr. Ram P. AGARWAL
Professor
University of Miami Medical Center
Miami, FL
[email protected]
Krishna C. AGRAWAL, Ph.D. (Deceased)
Regents Professor and Chairman
Department of Pharmacology
Tulane University School of Medicine
New Orleans, LA 70112
Thiru ARUMUGAM, Ph.D.
Senior Research Scientist
Dept of Cancer Biology
UT MD Anderson Cancer Center, Houston, TX77030
[email protected];
[email protected]
Dr. Shilpi ARORA
Scientist
Constellation Pharmaceuticals
Boston, MA
[email protected]
Dr. Shubha BAGRODIA
Scientist
Pfizer
San Diego, CA
[email protected]
Dr. Hamid BAND
Elizabeth Bruce Professor of Cancer Research at
Eppley Institute, and associate director of
translational research at the Fred & Pamela Buffett
Cancer Center
University of Nebraska Medical Center
Omaha, NE
[email protected]
Research Interests:
Pancreatic Cancer,
Chemoresistance,
Bioinformatics
Hobbies: Reading,
Music
Dr. Vimla BAND
Ardith & Anna Von Housen Professor
Chair, Department of Genetics, Cell Biology &
Anatomy
Associate Director of Center for Breast Cancer
Research
Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center
Omaha, NE
Delineate molecular
mechanisms of early
steps in transformation
of mammary epithelial
cells with the goal of
identifying novel
molecular
diagnostic/prognostic
markers and potential
Cancer genetics
Regulation of tyrosine
kinase-mediated cell
signaling with the longterm goal of developing
targeted therapeutics
and early
diagnostic/prognostic
markers for cancer
[email protected]
Dr. Prashant BAVI, M.D.
Postdoctoral Fellow
Dept Of Human Cancer Genomic Research
[email protected];
[email protected]
Website: http://www.linkedin.com/in/prashantbavi
Dr. Subhash CHAKRABARTY
Professor
Depart. of Microbiology, Immunology & Cell Biology
Simmons Cooper Cancer Institute
Southern Illinois University School of Medicine
Springfield, Illinois 62794‐9677
[email protected]
Dr. Dhrubajyoti CHAKRAVARTI, Ph.D.
Chief Scientist
4115 Harrison St, Bellevue, NE 68147
[email protected]
Website: http://www.life-120.com/
Dhyan Chandra, Ph.D. (JNU, India)
Assistant Professor
Dept. of Pharmacology & Therapeutics
Roswell Park Cancer Institute,
Elm & Carlton Streets,
Buffalo, NY14263
[email protected]
Chandradhar DWIVEDI, Ph.D. (Lucknow
University)
Distinguished Professor and Head,
Department of Pharmaceutical Sciences
College of Pharmacy, South Dakota State
University, Brookings, SD 57007
[email protected]
Dr. Bakul I. DALAL, M.D., FRCP
Hematopathologist
Vancouver General Hospital
Clinical Professor, University of British Columbia
Vancouver Coastal Health
11Th Floor 601 West Broadway
Vancouver, British Columbia V5Z 4C2
Canada
[email protected]
Dr. Rama S. DWIVEDI
Northwestern University
Chicago, IL
[email protected]
therapy targets of breast
cancers
Research Interests
Oncopathology:
Colorectal Cancer and
Thyroid Cancer,
validation of biomarkers,
improving efficacy of
tissue microarray
technology, Image
analysis, and tumor
biobanking
Mechanisms of growth
and differentiation
control in epithelial
cancer.
Research Interests:
Identify and develop
natural and synthetic
compounds that provide
protection against
environmental pollution.
Hobbies: Photography
Research Interest:
Apoptosis signaling,
cancer stem cells
Research InterestCancer prevention and
treatment
Hobbies- Reading,
spirituality, listening to
music, gardening
Hematopathology
Dr. Sanjiv Sam GAMBHIR
Virginia and D.K. Ludwig Professor for Clinical
Investigation in Cancer Research
Chair, Department of Radiology
Stanford University School of Medicine
Stanford, CA
[email protected]
Dr. Varsha GANDHI
Department of Experimental Therapeutics
UT M.D. Anderson Cancer Center
1515 Holcombe Blvd., Houston, TX 77030
[email protected]
Dr. Aniruddha GANGULY
National Cancer Institute
Bethesda, MD
[email protected]
Dr. Ramesh GANJU
Scott Endowed Chair and Professor
Vice Chair, Experimental Pathology
810 Biomedical Research Tower
460 West 12th Avenue
Columbus, OH 43210
[email protected]
Dr. Rita GHOSH
Assistant Professor
Department of Urology
The University of Texas Health Science Center at
San Antonio
7703 Floyd Curl Drive, Mail Code 7845
San Antonio, Texas 78229-3900
Phone: (210) 567-5664
[email protected]
Dr. Rayudu GOPALKRISHNA
Associate Professor
Cell and Neurobiology
Keck School of Medicine
University of Southern California
Health Sciences Camous
Los Angeles, CA 90089-9112
[email protected]
Dr. Sushovan GUHA, M.D., Ph.D.
Gastroenterologist
The University of Texas Health Sciences Center at
Houston
Medical School
6411 Fannin St,
Houston, TX 77030
Phone: (713) 704-4000
Dr. Rishab K. GUPTA
Wayne Cancer Institute, CA
[email protected]
Radiology/Nuclear
Medicine
Experimental
therapeutics
Mechanisms of tumor
development &
metastasis, tumor
microenvironment, brain
tumor biology, cancer
diagnostics, molecular
analysis technologies
Role of chemokines,
and various
inflammatory molecules,
and anti-inflammatory
molecules, in
pathogenesis of various
diseases
Study on deregulation of
DNA damage signaling
and cell cycle
progression in cancer
and use these pathways
as molecular targets to
develop strategies for
cancer prevention and
or therapy
Prostate cancer
prevention
Research Interests:
Novel signal
transduction pathways
in GI cancers and
chemoprevention of GI
cancer
Dr. Shanker L. GUPTA
Program Manager
Developmental Therapeutics Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
Bethesda, MD
[email protected]
Dr. Sudhir GUPTA, M.D.
Professor
[email protected]
Anti-cancer drug
development
Dr. Surendra GUPTA, Ph.D.
President
American Radiolabeled Chemicals, Inc.
Email: [email protected]
Website: www.arc-inc.com
Radiopharmaceuticals
Molecular signaling in
apoptosis
Memory CD4+ and
CD8+ T cells
Dendritic cell functions
Dr. Abid HUSSAIN
Dr. H.N. JAYARAM
Professor
Indiana University, IN
[email protected]
Dr. Anil K. JAISWAL
Professor
Department of Pharmacology
Howard Hall, 404
University of Maryland School of Medicine
Baltimore, MD
[email protected]
Dr. Madhavi KADAKIA
122 Diggs Laboratory
Dept. of Biochemistry & Molecular Biology
Wright State University
Dayton, OH 45435
[email protected]
Dr. Hari KAUL, Ph.D., FACN, FACN
Carroll W. Feist Endowed Chair
Professor & Chairman
Department of Biochemistry & Molecular Biology
School of Medicine LSUHSC- shreverport, LA
Associate Director, Feist Weiller Cancer Center
Phone (office):318-675-5161
[email protected]
Oxidative stress
signaling with a focus on
Nrf2:INrf2 (Keap1)
signaling; cell survival
and death;
chemoprevention;
oncogenesis with focus
on hematological
malignancies, skin,
breast and prostate
cancer, and metastasis;
drug resistance; and
bioreductive drug
development.
Dr. Meena KATDARE, (University of Pune, India,
1978)
Director, Carcinogenesis and Chemoprevention
Laboratory
Weill Cornell Medical College
1300 York Avenue, Box-287, New York, NY 10021
Ph: 212-746-5431 - [email protected]
http://www.cornellsurgery.org/pro/research/biosketch
es.html
Dr. Koyamangalath KRISHNAN, MD, FRCP, FACP
Dishner Endowed Chair of Excellence in Medicine
Professor of Medicine
Division Chief of Hematology/Oncology
Department of Clinical Cancer Prevention, Division
of Cancer Prevention and Population Sciences,
The UT MD Anderson Cancer Center, Houston, TX
77030
[email protected]
Dr. Raju KUCHERLAPATI
Paul C. Cabot Professor, Department of Genetics,
Harvard Medical School
Professor, Department of Medicine
Scientific Director, Harvard-Partners Center for
Genetics and Genomics, Partners HealtheCare
System, Brigham And Women's Hospital
Boston, MA
[email protected]
Dr. Rakesh KUMAR
Birch & McCormick Chair
Catharine Birch and William P. McCormick Chair of
Biochemistry and Molecular Biology
Professor
George Washington University School of Medicine
Washington, DC
[email protected]
Dr. Shaji KUMAR, (M.D.)
Associate Professor
Mayo Clinic, Rochester, MN 55905
[email protected]
Research Interests:
Signal transduction
pathways of
carcinogenesis and
chemoprevention
of breast, colon,
prostate and thyroid
cancers
Hobbies: Gardening,
Interior Decoration,
Knitting, Dress
designing, Travel, Indian
Music
Cloning and
characterization of
human disease genes
with a focus on human
syndromes with a
significant
cardiovascular
involvement; use of
genetic/genomic
approaches to
understand the biology
of cancer and the
generation and
characterization of
genetically modified
mouse models for
cancer and other human
disorders.
Research Interests:
Interactions between
malignant plasma cells
and the marrow
microenvironment in
plasma cell
malignancies; develop
new therapeutic
approaches to target
these interactions and
enhance the efficacy of
the currently available
therapies.
Dr. Aroop MANGALIK, M.D.
Hematology
900 Camino de Salud NE
1 University of New Mexico
Albuquerque, NM 87131
Dr. Kapil MEHTA, (Ph.D., PGI, Chandigarh, India)
Professor of Cancer Medicine (Biochemistry)
Univ of Texas M. D. Anderson Cancer Center
Houston, TX 77030
(http://www.mdanderson.org/departments/expther/)
Email: [email protected]
Research interests:
Chemoresistance,
metastasis,
retinoids, drug delivery
systems
Hobbies: Reading,
gardening, music
Rajendra G. MEHTA, Ph.D.
Assistant Vice President, Professor and Head
IIT Research Institute and IIT
Chicago, IL 60616
[email protected]
Research Interests:
Efficacy and molecular
mechanism(s) of action
of chemopreventive
agents including Vitamin
D and Resveratrol in
breast, colon and lung
cancer models.
Dr. Krishna MENON
Scientist/Business owner
Cell Centix Inc.
Beverly, MA
[email protected]
Dr. Lopa MISHRA (M.D.)
Chair, Gastroenterology, Hepat. & Nutrition
MD Anderson Cancer Center
1515 Holcombe Blvd
Houston, TX 77030
Email: [email protected]
In vivo and vitro
preclinical testing
Dr. Debasish MONDAL
Associate Professor
Department of Pharmacology
Tulane University
New Orleans, LA
[email protected]
HIV-1 induced
pathogenesis; role of
HIV-1 transactivator
(Tat) protein in
regulating viral latency
and infectivity;
pharmacological
interventions to enhance
efficacy and reduce
toxic side effects of antiretroviral drugs
Gastroenterology
Dr. Hasan MUKHTAR
Professor
Department of Dermatology
University of Wisconsin
School of Medicine & Public Health
Madison, WI
[email protected]
Molecular target based
approaches for
prevention and
treatment of cancer and
skin disease psoriasis
by phytochemicals
Dr. Anuradha MURALI
Microbiology and Immunology
Medical University of South Carolina
Charleston, USA
[email protected]
Dr. Harikrishna NAKSHATRI
Marian J. Morrison Professor of Surgery
Indiana University School of Medicine
Indianapolis, IN
[email protected]
Dr. Pratima NANGIA-MAKKER
Assistant Professor
Wayne State University, Detroit, MI 48201
[email protected]
Dr. Satyabrata NANDI
Professor Emeritus of Cell & Developmental Biology
University of California, Berkeley, CA
[email protected]
Dr. Shanker NAYAK
(Diseased)
Director, Diagnostics
Hoag Cancer Center
New Port Beach, CA
Activation of NF-kB in
estrogen receptor
negative breast cancer.
The focus is on genomic
aspects of anti-estrogen
resistance, mechanisms
of organ-specific
metastasis and
biomarkers of breast
cancer progression and
therapeutic response
Research Interests:
Role of carbohydratebinding protein
galectin-3 in cancer
progression and
metastasis. We are also
studying the inhibitory
effects of natural plant
products on cancer
progression
Determine the biological
and molecular bases for
susceptibility and
resistance to breast
carcinogenesis as well
as for the prevention of
breast cancer
Gene vaccine therapy,
Preclinical cancer
research
Dr. Arokya Mary S. PAPU JOHN
Postdoctoral Research Associate
Biomedical & Diagnostic Sciences
University of Tennessee
Knoxville, TN
[email protected]
Cancer Diagnostics
Dr. Sen PATHAK
Professor
Cytogenetics
MD Anderson cancer Center
Houston, TX
[email protected]
Cancer cytogenetics
Dr. Subbarayan R POCHI (Ph.D., Banaras Hindu
University, 1994)
Research Assistant Professor
Department of Medicine
Division of Hematology and Oncology
University of Miami Miller School of Medicine
Miami, FL - 33176
Research Interests: 5FU
resistance,
Pharmocogenomics,
Ethno botanicals
Hobbies: Reading,
Traveling by road,
Community work.
Dr. Raj PURI, M.D., Ph.D.
Division Director, Food and Drug
Administration,
Bethesda, MD
Research Interests:
[email protected]
Dr. Govind RAGUPATHI
Associate Attending Immunologist
Memorial Sloan-Kettering Cancer Center
New York, NY 10065
Tel: (646) 888 2363
Fax: (646) 422 0516
E-mail: [email protected]
Develop monoclonal
antibodies, optimize
vaccines that induce
antibody responses, and
produce and test new
immunological
adjuvants to augment
these responses
Dr. Ranju RALHAN
Department of Pathology and Laboratory Medicine
Joseph & Wolf Lebovic Health Complex
Mt. Sinai Hospital
600 University Ave., Room 6-416
Toronto, ON M5G 1X5
[email protected]
Translational cancer
research, molecular
diagnostics proteomics,
genomics, epigenomics,
cancer biology, cell
biology, targeted
therapy
Dr. Chandra RAMANATHAN, Ph.D., MBA
Scientist, Head Early Pipeline Oncology
Bayer HealthCare Pharmaceuticals
West Haven, Connecticut 06516
[email protected]
Dr. Aramandla RAMESH
Associate Professor
Biochemistry & Cancer Biology
Meharry Medical College
Nashville, TN
[email protected]
Environmental
Toxicology, Chemical
Carcinogenesis
Dr. Kaladhar B. REDDY
Professor
Wayne State University School of Medicine
540 East Canfield Avenue
Detroit, MI 48201
[email protected]
Novel strategies for
treatment and prognosis
of breast cancer by
combining experimental
therapeutics with cell
biology; cancer stem
cells
Dr. Shrikanth REDDY
Department of GI Med Oncology
MD Anderson Cancer Center
1515 Holcombe Blvd
Box 0956
Houston, TX 77030
[email protected]
Dr. Fazlul SARKAR
Distinguished Professor
Department of Pathology
Karmanos Cancer Institute
Detroit, MI
[email protected]
Dr. D. S. R. SARMA
Professor
University of Toronto, Canada
[email protected]
Dr. Neeraj SAXENA
Assistant Professor
University of Maryland School of Medicine
Baltimore, MD
[email protected]
Dr. Senthamil SELVAN
Vice-President R&D
Omni Array Biotechnology
15601 Crabbs Branch Way
Rockville, MD
[email protected]
Dr. Subrata SEN
Professor & Deputy Chair, Department of
Translational Molecular Pathology, Division of
Pathology/Lab Medicine, The University of Texas
MD Anderson Cancer Center, Houston, TX
Phone: (713) 834-6040
Email: [email protected]
Role of NF-κB and its
signaling molecules in
solid tumors, and in
elucidating the
molecular mechanisms
of action of “natural
agents” for cancer
prevention and therapy
Links between obesity,
adipocytokines and
carcinogenesis
Cancer Immunotherapy
Functional
characterization of the
genes regulating mitotic
chromosome
segregation and
elucidation of their role
in the induction of
chromosomal instability
in cancer
Dr. Shyam SHARAN
Deputy Program Director, Mouse Cancer Genetics
Prog.
Senior Investigator
Head, Genetics of Cancer Susceptibility Section
Center for Cancer Research
National Cancer Institute, Frederick, MD
[email protected]
Dr. Dipali SHARMA
Associate Professor of Oncology
Kimmel Cancer Center
Johns Hopkins University
Baltimore, MD
[email protected]
DNA repair, hereditary
Breast cancer, tumor
suppressor, mouse
models, recombineering,
BRCA1/2 variants
Breast Cancer, ObesityCancer Connection,
Adipocytokines,
Metastasis, Tamoxifen
Resistance, Novel
Therapeutics, Bioactive
Food Components,
Signaling Mechanisms
Dr. Zahid H. SIDDIK
Scientist
UTMD Anderson Cancer Center
Houston, TX
[email protected]
Dr. Promila SINGH
Professor
Department of Biochemistry & Molecular Biology
University of Texas Medical Branch
Galveston, TX
[email protected]
Dr. Sujay SINGH
President and CEO
ABGENEX Corp.
San Diego, CA
[email protected]
Cancer diagnostics,
Biotechnology
development
Dr. Anant SHRIKANT
Professor of Molecular and Integrative Physiology
and Surgery
University of Kansas Medical Center
Kansas
[email protected]
Interest in
understanding the
mechanisms that
regulate gene
expression at the
posttranscriptional levels
of mRNA stability and
translation during
tumorigenesis
Research Interest: Rol
e of mitochondria in
cancer, Inter
genomic crosstalk and
its role tumorigenesi
s and mitochondrial
diseases
Hobbies: Kite flying,
traveling
Dr. Keshav K. SINGH
Professor of Oncology
Roswell Park Cancer Institute
Buffalo, NY, 14263
www.keshavsingh.org
Dr. Raghu SINHA (Ph.D., PGIMER, Chandigarh,
India)
Associate Professor
Penn State College of Medicine, Hershey,
Pennsylvania
Website link:
http://fred.psu.edu/ds/retrieve/fred/investigator/rus15
[email protected]
Dr. Taduru SREENATH
Assistant Director, CPDR Basic Science Research
Program,
The Henry M. Jackson Foundation
Research Assistant Professor of Surgery
USUHS
[email protected]
Research Interests:
Breast cancer model
systems, molecular
mechanisms of
prevention in breast and
prostate cancers.
Dr. Saraswati SUKUMAR
Barbara B. Rubenstein Professor of Oncology
Johns Hopkins University School of Medicine,
Baltimore, MD21231
[email protected]
Research Interests:
Discovery and study of
molecular alterations in
breast cancer. Methods
and markers for early
detection and prognosis.
Cancer diagnostics
Dr. Atul TANDON
President & CEO
NeoBiotechnologies, Inc.
Union City, CA
[email protected]
Dr. Rajeshwar Rao TEKMAL
Carl J. Pauerstein Professor in Reproductive
Research, Director, Division of Reproductive
Research
Department of Obstetrics and Gynecology
University of Texas Health Science Center at San
Antonio
San Antonio, TX 78229-3900
Tel: 210-567-4930; Direct: 210-567-4935
[email protected]
Dr. Nityanand T. TELANG
Roswell Park Cancer Institute
Buffalo, NY
[email protected]
Dr. T. J. THOMAS
Professor
R.W. Johnson Medical Center
Rutgers University, NJ
[email protected]
[email protected]
Dr. Ratna K. VADLAMUDI
Professor
Department of Obstetrics & Gynecology
UTHSCSA, San Antonio, TX
[email protected]
Ph. (210) 567-4930
Scientific interests focus
on understanding
molecular mechanisms
underlying prostate
cancer initiation and
development using
mouse models
Role of hormones
and growth factors and
their receptors in the
initiation and
progression of breast,
cervical and ovarian
cancers.
Develop novel DNA
delivery vehicles for
gene therapy. The
current focus is on
breast cancer
Research Interests:
Estrogen signaling,
Hormonal therapy
resistance, Nuclear
receptors, Signal
transduction, Tg/KO
mouse models for
cancer
Dr. Hariprasad VANKAYALAPATI
Scientist/Medicinal chemist
Draper, UT
[email protected]
[email protected]
Dr. Atul VARADHACHARI, M.D.
President & Chief Operating Officer
Agennix, Inc., Houston, TX
[email protected]
Dr. Arti PATEL VARANASI,, Ph.D., M.P.H.
President & CEO
Advancing Synergy, LLC
1450 South Rolling Road
Baltimore, MD 21227
www.advancingsynergy.com
[email protected]
Siva VENUGOPAL
Sugar Land, TX
Engineering/bioinformatics company owner
[email protected]
Dr. Inder VERMA
Professor
Laboratory of Genetics
American Cancer Society Professor of Molecular
Biology
Irwin and Joan Jacobs Chair in Exemplary Life
Science
The Salk Institute for Biological Studies
La Jolla, CA
[email protected]
Dr. Ajit K. VERMA (Univ of South Australia,
Adelaide)
Professor, University of Wisconsin
Madison, WI 53792
weblink: www.med.wisc.edu/metc/fac/fac53.php.
E-mail: [email protected]
Dr. Meena VORA
Scientist/Business owner
Biosphare
Fremont, CA
[email protected]
Cancer research, public
health, advocacy,
capacity building and
project management
Gene therapy for
cancer; developed
viruses for gene therapy
vectors; developed a
gene therapy vector,
based on a strippeddown version of HIV,
that can deliver genes to
non-dividing cells, which
constitute majority of the
cells in our bodies.
Research interests:
etiology and prevention
of skin and prostate
cancer. PKCepsilon
signal transduction
pathways
Hobbies: fishing and
gardening.
Dr. Mansukh WANI
Principal Scientist (Retired)
Research Triangle Institute, NC 27709
www.rti.org/naturalproducts
[email protected]
Research Interests:
Discovery of Anticancer
Agents of Diverse
Natural Origin